304 related articles for article (PubMed ID: 20031643)
1. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
Rotger M; Bayard C; Taffé P; Martinez R; Cavassini M; Bernasconi E; Battegay M; Hirschel B; Furrer H; Witteck A; Weber R; Ledergerber B; Telenti A; Tarr PE;
Circ Cardiovasc Genet; 2009 Dec; 2(6):621-8. PubMed ID: 20031643
[TBL] [Abstract][Full Text] [Related]
2. Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
Egaña-Gorroño L; Martínez E; Cormand B; Escribà T; Gatell J; Arnedo M
AIDS; 2013 Feb; 27(4):529-38. PubMed ID: 23262498
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.
Tarr PE; Rotger M; Telenti A
Pharmacogenomics; 2010 Apr; 11(4):587-94. PubMed ID: 20350140
[TBL] [Abstract][Full Text] [Related]
4. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
Tarr PE; Taffé P; Bleiber G; Furrer H; Rotger M; Martinez R; Hirschel B; Battegay M; Weber R; Vernazza P; Bernasconi E; Darioli R; Rickenbach M; Ledergerber B; Telenti A;
J Infect Dis; 2005 May; 191(9):1419-26. PubMed ID: 15809899
[TBL] [Abstract][Full Text] [Related]
5. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
[TBL] [Abstract][Full Text] [Related]
7. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
Arnedo M; Taffé P; Sahli R; Furrer H; Hirschel B; Elzi L; Weber R; Vernazza P; Bernasconi E; Darioli R; Bergmann S; Beckmann JS; Telenti A; Tarr PE;
Pharmacogenet Genomics; 2007 Sep; 17(9):755-64. PubMed ID: 17700364
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy.
Swanson B; Keithley JK; Zeller JM; Sha BE
Nutrition; 2004; 20(11-12):1022-5. PubMed ID: 15561494
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
Rimland D; Guest JL; Hernández I; Del Rio C; Le NA; Brown WV
HIV Med; 2005 Sep; 6(5):326-33. PubMed ID: 16156880
[TBL] [Abstract][Full Text] [Related]
10. Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.
Tarr PE; Telenti A
Antivir Ther; 2007; 12(7):999-1013. PubMed ID: 18018758
[TBL] [Abstract][Full Text] [Related]
11. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
12. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
Hiransuthikul N; Hiransuthikul P; Kanasook Y
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions.
Heid IM; Boes E; Müller M; Kollerits B; Lamina C; Coassin S; Gieger C; Döring A; Klopp N; Frikke-Schmidt R; Tybjaerg-Hansen A; Brandstätter A; Luchner A; Meitinger T; Wichmann HE; Kronenberg F
Circ Cardiovasc Genet; 2008 Oct; 1(1):10-20. PubMed ID: 20031538
[TBL] [Abstract][Full Text] [Related]
14. Large scale replication analysis of loci associated with lipid concentrations in a Japanese population.
Nakayama K; Bayasgalan T; Yamanaka K; Kumada M; Gotoh T; Utsumi N; Yanagisawa Y; Okayama M; Kajii E; Ishibashi S; Iwamoto S;
J Med Genet; 2009 Jun; 46(6):370-4. PubMed ID: 19487539
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
16. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol levels in HIV-HCV infected patients treated with lopinavir/r: results from the SCOLTA project.
De Socio GV; Bonfanti P; Ricci E; Orofino G; Madeddu G; Penco G; Gianelli E; Martinelli C; Carradori S; Quirino T; Rizzardini G;
Biomed Pharmacother; 2008 Jan; 62(1):16-20. PubMed ID: 17851026
[TBL] [Abstract][Full Text] [Related]
19. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
Visnegarwala F; Maldonado M; Sajja P; Minihan JL; Rodriguez-Barradas MC; Ong O; Lahart CJ; Hasan MQ; Balasubramanyam A; White AC
J Infect; 2004 Nov; 49(4):283-90. PubMed ID: 15474625
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART).
Lapphra K; Vanprapar N; Phongsamart W; Chearskul P; Chokephaibulkit K
J Med Assoc Thai; 2005 Jul; 88(7):956-66. PubMed ID: 16241026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
